Impact of device-aided therapies on QoL and Off-time improvement in advanced Parkinson’s Disease patients: Comparative effectiveness results from a Bayesian Network Meta-Analysis
Objective: To compare off-time and QoL changes among APD patients taking LCIG, DBS, CSAI, and BMT at 6 months after therapy initiation. Background: Advanced Parkinson’s…Deep Brain Stimulation of Anterior Globus Pallidus internus Reduces Impulsivity in Parkinson’s Disease
Objective: To evaluate whether selective deep brain stimulation (DBS) stimulation of anterior region of globus pallidus internus (GPi) affects impulsivity in Parkinson’s Disease patients Background:…Comparison of video-instructed and operator-instructed markerless motion analysis with clinical rating-scales in patients with Parkinson’s Disease
Objective: This study aims to compare video-instructed and operator-instructed RGB-Depth (RGBD) camera assessments with clinical ratings scales for gait and balance in patients with Parkinson’s Disease…Multimodal Conversational AI for Remote Patient Monitoring and Analysis of Parkinson’s Disease
Objective: To present, analyze and evaluate a cloud-based audio-visual dialog agent and its associated automated speech, face and movement analytics for remote patient monitoring in…Preliminary validation of an educational handbook for Parkinson’s disease patients in Brazil
Objective: To describe the development and preliminary validation of an educational handbook for Parkinson’s disease (PD) patients. Background: PD is a progressive, chronic and heterogeneous…Patient-Reported Impact of Standard-of-Care: Change in Symptoms Following Dopamine Initiation and Deep Brain Stimulation
Objective: The goal of this study was to describe changes in patient-reported symptoms following initiation of standard-of-care treatment strategies in Parkinson’s disease (PD). Background: A…The role of community engagement and involvement in Parkinson’s disease research: a case study from Africa
Objective: Using a case study from Africa to understand the potential role of community engagement and involvement (CEI) in future research on Parkinson’s disease (PD).…Evaluating Patients’ Preferences for Parkinson’s Disease Treatments
Objective: To identify patients’ preferences for attributes of oral medications that are added to levodopa or levodopa/carbidopa (LD/CD) regimens to reduce OFF-time for Parkinson’s disease…Modeling of the Placebo Response in Parkinson’s Disease
Objective: The objective of this study was to investigate the predictability of the placebo response in Parkinson's disease (PD) subjects participating in a randomized clinical…Effect of probiotics on MDS UPDRS in Parkinson disease at 12 weeks: A Randomized double-blind placebo-controlled trial
Objective: The primary objective was to find the effect of 12 weeks of probiotic supplementation on MDS UPDRS score in Parkinson’s Disease. The secondary objectives…
- « Previous Page
- 1
- …
- 430
- 431
- 432
- 433
- 434
- …
- 436
- Next Page »